A new prostaglandin E1 analogue (TFC-612) improves the reduction in motor nerve conduction velocity in spontaneously diabetic GK (Goto-Kakizaki) rats.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Prostaglandins

• Publication date

  1990-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0090-6980(90)90109-9PMID 2255766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats.

  1988cited by this paper
• Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy

  1987cited by this paper
• Sural nerve oxygen tension in diabetes.

  1986cited by this paper
• E-type prostaglandins depolarize primary afferent neurons of the neonatal rat.

  1986cited by this paper
• Dehydration and epimerization of 7-thiaprostaglandin E1 analogues.

  1986cited by this paper
• Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy

  1986cited by this paper
• Capillary number and percentage closed in human diabetic sural nerve.

  1985cited by this paper
• Synthesis of 7-thiaprostaglandin E1 congeners: potent inhibitors of platelet aggregation.

  1985cited by this paper
• Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy.

  1984cited by this paper
• Excessive Nonenzymatic Glycosylation of Peripheral and Central Nervous System Myelin Components in Diabetic Rats

  1983cited by this paper
• Peripheral neuropathy in selectively-inbred spontaneously diabetic rats: electrophysiological, morphometrical and freeze-replica studies.

  1982cited by this paper
• Electron microscopical studies of vessels in diabetic peripheral neuropathy.

  1980cited by this paper
• Production of spontaneous diabetic rats by repetition of selective breeding.

  1976cited by this paper
• Intravenous prostaglandin E1 in severe peripheral vascular disease.

  1976cited by this paper
• Prostaglandins in hematology.

  1974cited by this paper
• Serial in vivo determinations of nerve conduction velocity in rat tails. Physiological and pathological changes.

  1973cited by this paper
• The sorbitol pathway and the complications of diabetes.

  1973cited by this paper
• Identification of sorbitol in mammalian nerve.

  1966cited by this paper
• Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in Diabetes

  1966cited by this paper

• Diabetic rats with high levels of endogenous dopamine do not show retinal vascular pathology

  2023cites this paper
• Treatment for diabetic peripheral neuropathy: What have we learned from animal models?

  2021cites this paper
• Retinal Deficits Precede Cognitive and Motor Deficits in a Rat Model of Type II Diabetes.

  2019cites this paper
• The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat.

  2004cites this paper
• Effects of sulbutiamine on diabetic polyneuropathy: an open randomised controlled study in type 2 diabetics.

  2002cites this paper
• Nerve conduction impairment in experimental diabetes—proximodistal gradient of severity

  1999cites this paper
• Peripheral neuropathies in diabetes.

  1998cites this paper
• Latency of neuroactivity and optimum period of treatment with evening primrose oil in diabetic rats.

  1996cites this paper
• Metabolic Alterations of Peripheral Nerve in Diabetes

  1996cites this paper
• Effects of Beraprost Sodium and Insulin on the Electroretinogram, Nerve Conduction, and Nerve Blood Flow in Rats with Streptozotocin-Induced Diabetes

  1996cites this paper
• Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes.

  1995cites this paper
• Vasoreactivity to prostaglandins of rat peripheral nerve.

  1995cites this paper
• Diabetic Neuropathy in the Elderly

  1995cites this paper
• Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy.

  1995cites this paper
• Diabetic neuropathies.

  1995cites this paper
• The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications.

  1994cites this paper
• Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage.

  1993cites this paper
• Prostacyclin release in experimental diabetes: effects of evening primrose oil.

  1993cites this paper
• Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost

  1993cites this paper
• Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats

  1993cites this paper
• Potential Therapeutic Approaches to the Treatment or Prevention of Diabetic Neuropathy: Evidence from Experimental Studies

  1993cites this paper
• Complications: Neuropathy, Pathogenetic Considerations

  1992cites this paper
• The pharmacology of diabetic neuropathy.

  1992cites this paper
• Syntheses of 3H- and 2H-labeled (17R)-17,20-dimethyl-7-thiaprostaglandin E1 methyl ester

  1991cites this paper